Zu‐Yin Yu

654 total citations
27 papers, 561 citations indexed

About

Zu‐Yin Yu is a scholar working on Molecular Biology, Biomaterials and Hematology. According to data from OpenAlex, Zu‐Yin Yu has authored 27 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Biomaterials and 6 papers in Hematology. Recurrent topics in Zu‐Yin Yu's work include Phytochemistry and Bioactive Compounds (8 papers), Phytochemical Studies and Bioactivities (7 papers) and Acute Myeloid Leukemia Research (6 papers). Zu‐Yin Yu is often cited by papers focused on Phytochemistry and Bioactive Compounds (8 papers), Phytochemical Studies and Bioactivities (7 papers) and Acute Myeloid Leukemia Research (6 papers). Zu‐Yin Yu collaborates with scholars based in China, Czechia and United States. Zu‐Yin Yu's co-authors include Yuwen Cong, Liping Kang, Baiping Ma, Da‐Wei Tan, Yajun Shan, Yixun Liu, Yang Zhao, Yu Zhao, Sai Wang and Yang Cong and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Zu‐Yin Yu

27 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zu‐Yin Yu China 12 417 119 80 62 61 27 561
Bowen Liu China 16 426 1.0× 28 0.2× 49 0.6× 30 0.5× 86 1.4× 49 617
Xin Cai China 13 178 0.4× 46 0.4× 53 0.7× 5 0.1× 41 0.7× 39 545
Jianli Liu China 15 271 0.6× 112 0.9× 30 0.4× 24 0.4× 41 0.7× 45 591
Yunfei Li China 11 177 0.4× 47 0.4× 66 0.8× 13 0.2× 47 0.8× 33 387
Guang Wan China 13 183 0.4× 31 0.3× 12 0.1× 25 0.4× 49 0.8× 14 375
Yanbin Guan China 13 227 0.5× 61 0.5× 96 1.2× 21 0.3× 29 0.5× 28 429
Qiaoli Shi China 10 199 0.5× 47 0.4× 16 0.2× 10 0.2× 51 0.8× 23 398
Jia Lai China 9 127 0.3× 64 0.5× 15 0.2× 7 0.1× 92 1.5× 29 351
Dandan Jiang China 13 240 0.6× 56 0.5× 32 0.4× 11 0.2× 98 1.6× 29 449

Countries citing papers authored by Zu‐Yin Yu

Since Specialization
Citations

This map shows the geographic impact of Zu‐Yin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zu‐Yin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zu‐Yin Yu more than expected).

Fields of papers citing papers by Zu‐Yin Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zu‐Yin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zu‐Yin Yu. The network helps show where Zu‐Yin Yu may publish in the future.

Co-authorship network of co-authors of Zu‐Yin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zu‐Yin Yu. A scholar is included among the top collaborators of Zu‐Yin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zu‐Yin Yu. Zu‐Yin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Xing, et al.. (2025). Intersection of Cardio‐Oncology: An Overview of Radiation‐Induced Heart Disease in the Context of Tumors. Journal of the American Heart Association. 14(10). e040937–e040937. 2 indexed citations
2.
Wang, Renxi, Jing Wang, Guojiang Chen, et al.. (2024). Development and characterization of an antibody that recognizes influenza virus N1 neuraminidases. PLoS ONE. 19(5). e0302865–e0302865. 1 indexed citations
3.
Shen, Xing, et al.. (2020). Salt-inducible kinase inhibition sensitizes human acute myeloid leukemia cells to all-trans retinoic acid-induced differentiation. International Journal of Hematology. 113(2). 254–262. 1 indexed citations
4.
Shen, Xing, Shuang Xing, Lu Zhang, et al.. (2018). Vibsanin A sensitizes human acute myeloid leukemia cells to tyrosine kinase inhibitor-induced myeloid differentiation via activation of PKC and upregulation of Lyn. Biochemical and Biophysical Research Communications. 502(1). 110–115. 7 indexed citations
5.
Li, Zhongtang, Limei Wang, Xiaohui Lin, et al.. (2017). Flucrypyrim, a novel uterine relaxant, has antinociceptive and anti-inflammatory effects in vivo. Scientific Reports. 7(1). 42040–42040. 5 indexed citations
6.
Yu, Zu‐Yin, Limei Wang, Xing Shen, et al.. (2016). Natural Product Vibsanin A Induces Differentiation of Myeloid Leukemia Cells through PKC Activation. Cancer Research. 76(9). 2698–2709. 30 indexed citations
8.
Wang, Limei, Chao Jia, Zu‐Yin Yu, et al.. (2012). Pennogenin Tetraglycoside Induces Rat Myometrial Contraction and MLC20 Phosphorylation via PLC-IP3 and RhoA/Rho Kinase Signaling Pathways. PLoS ONE. 7(12). e51536–e51536. 10 indexed citations
9.
Liu, Xiaolan, Liping Kang, Zu‐Yin Yu, et al.. (2012). Pennogenin tetraglycoside stimulates secretion-dependent activation of rat platelets: Evidence for critical roles of adenosine diphosphate receptor signal pathways. Thrombosis Research. 129(5). e209–e216. 15 indexed citations
10.
Kang, Liping, Jie Zhang, Bin Li, et al.. (2012). Steroidal Glycosides from the Rhizomes ofAnemarrhena asphodeloidesand Their Antiplatelet Aggregation Activity. Planta Medica. 78(6). 611–616. 42 indexed citations
11.
Li, Ming, Zu‐Yin Yu, Shuang Xing, et al.. (2011). High dose granulocyte colony-stimulating factor enhances survival and hematopoietic reconstruction in canines irradiated by 2.3 Gy mixed fission neutron and gamma ray.. PubMed. 19(4). 991–8. 5 indexed citations
12.
Sheng, Yuanjian, Jie Gao, Wenlong Hu, et al.. (2010). Follow-up study identifies two novel susceptibility loci PRKCB and 8p11.21 for systemic lupus erythematosus. Lara D. Veeken. 50(4). 682–688. 51 indexed citations
13.
Yu, Zu‐Yin, Rui Huang, Wenfeng Sun, et al.. (2010). Fluacrypyrim, a novel STAT3 activation inhibitor, induces cell cycle arrest and apoptosis in cancer cells harboring constitutively‐active STAT3. International Journal of Cancer. 127(6). 1259–1270. 24 indexed citations
14.
Li, Ming, Shuang Xing, Yanfang Zhao, et al.. (2010). [Effect of rhG-CSF on blood coagulation in beagles irradiated by 2.3 Gy neutron].. PubMed. 18(6). 1520–4. 1 indexed citations
15.
Yu, Zu‐Yin, et al.. (2008). Pennogenin glycosides with a spirostanol structure are strong platelet agonists: structural requirement for activity and mode of platelet agonist synergism. Journal of Thrombosis and Haemostasis. 6(3). 524–533. 64 indexed citations
17.
Zhao, Yu, Liping Kang, Yixun Liu, et al.. (2008). Steroidal Saponins from the Rhizome ofParis polyphyllaand Their Cytotoxic Activities. Planta Medica. 75(4). 356–363. 97 indexed citations
18.
He, Xiao, Jiannan Feng, Zu‐Yin Yu, et al.. (2007). A5, a New Small-Molecule Inhibitor of CD4 D1 Obtained from a Computer-Aided Screening Method, Contributes to the Inhibition of CD4+ T-cell Function. SLAS DISCOVERY. 12(6). 800–808. 2 indexed citations
19.
He, Xiao, Han Zhang, Zu‐Yin Yu, et al.. (2007). J2 prolongs the corneal allograft survival through inhibition of the CD4+ T cell-mediated response in vivo. Transplant Immunology. 18(2). 130–137. 6 indexed citations
20.
Yu, Zu‐Yin, Yajun Shan, Bo Dong, et al.. (2007). Melissoidesin G, a diterpenoid purified fromIsodon melissoides, induces leukemic‐cell apoptosis through induction of redox imbalance and exhibits synergy with other anticancer agents. International Journal of Cancer. 121(9). 2084–2094. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026